Skip to main content

Emilia Arturo

Institution
La Jolla Institute for Immunology

Projects

Broad-spectrum inhibitors of ebolavirus entry

Lead Institution
La Jolla Institute for Immunology
Principal Investigator
Erica Saphire
There are six known viruses in the ebolavirus genus, at least three of which are known to cause severe hemorrhagic fever in humans. All ebolaviruses display one surface protein, a glycoprotein termed…

Medical Defenses Against Emerging Infectious Disease

Lead Institution
La Jolla Institute for Immunology
Principal Investigator
Erica Saphire
Hemorrhagic fever viruses like Ebola, Marburg, and Lassa cause up to 90% lethality. To study these re-emerging threats to human health and develop the needed vaccines and antivirals, our laboratory…

Structural analysis of the sole surface glycoprotein of Machupo virus

Lead Institution
La Jolla Institute for Immunology
Principal Investigator
Kathryn Hastie
Machupo virus (MACV) was discovered in the 1960s and has remained endemic to Bolivia, causing several sporadic outbreaks of the highly lethal human disease, Bolivian Hemorrhagic Fever (BHF). No…